Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab

Cancer Chemotherapy and Pharmacology

Volumn 65, Issue 5, 2010, Pages 1001-1004

  Gourley, Brett L ^a   Mesa, Hector ^b   Gupta, Pankaj ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

ADAMTS 13 protein, human; Gemcitabine; Non small cell lung carcinoma; Rituximab; Thrombotic thrombocytopenic purpura

Indexed keywords

ANTIHYPERTENSIVE AGENT; BILIRUBIN; CARBOPLATIN; CREATININE; DISINTEGRIN; FIBRINOGEN; GEMCITABINE; GLUCOCORTICOID; HAPTOGLOBIN; HYDROCORTISONE; LACTATE DEHYDROGENASE; METALLOPROTEINASE; PREDNISONE; RITUXIMAB; STEROID; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADJUVANT THERAPY; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BRONCHOSCOPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CASE REPORT; COOMBS TEST; CREATININE BLOOD LEVEL; DEEP VEIN THROMBOSIS; DISEASE COURSE; DRUG DOSE REDUCTION; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HEMOLYTIC UREMIC SYNDROME; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG NON SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE SCLEROSIS; PARTIAL THROMBOPLASTIN TIME; PLASMAPHERESIS; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; URTICARIA;

ANTIBODIES, MONOCLONAL; ANTIMETABOLITES, ANTINEOPLASTIC; BLOOD CELL COUNT; BLOOD PLATELETS; CREATININE; DEOXYCYTIDINE; HEMOGLOBINS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 77649186197     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-010-1258-4     Document Type: Article

References (18)

1. A Bharthuar L Egloff J Becker M George JW Lohr G Deeb RV Iyer 2009 Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case report Cancer Chemother Pharmacol 64 177 181 10.1007/s00280-008-0900-x 1:CAS:528: DC%2BD1MXlt1Kjsb8%3D 19116715
2. SR Cataland HM Wu 2005 Immunotherapy for thrombotic thrombocytopenic purpura Curr Opin Hematol 12 359 363 10.1097/01.moh.0000170534.33517.99 1:CAS:528:DC%2BD2MXhtVersLvK 16093780 (Pubitemid 41284969)
3. D De Smet K Jochmans B Neyns 2008 Development of thrombotic thrombocytopenic purpura after a single dose of gemcitabine Ann Hematol 87 495 496 10.1007/s00277-007-0429-9 18097666
4. J Desrame C Duvic C Bredin D Bechade P Artru C Brezault G Defuentes JM Poirier LM Dourthe G Coutant S Chaussade A de Gramont JP Algayres 2005 Hemolytic uremic syndrome as a complication of gemcitabine treatment: report of six cases and review of the literature Rev Med Interne 26 179 188 10.1016/j.revmed.2004. 11.016 1:STN:280:DC%2BD2M7ks1yguw%3D%3D 15777580
5. CD Flombaum JA Mouradian ES Casper RA Erlandson F Benedetti 1999 Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine Am J Kidney Dis 33 555 562 10.1016/S0272-6386(99)70194-0 1:STN:280:DyaK1M7mvVCluw%3D%3D 10070921
6. MC Fung AM Storniolo B Nguyen M Arning W Brookfield J Vigil 1999 A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy Cancer 85 2023 2032 1:STN:280:DyaK1M3jslOmtA%3D%3D 10223245
7. M Gross C Hiesse F Kriaa F Goldwasser 1999 Severe hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and gemcitabine Anticancer Drugs 10 533 536 10.1097/00001813-199907000-00004 1:CAS:528:DyaK1MXls1agu74%3D 10885900
8. JA Hovinga JD Studt L Alberio B Lammle 2004 von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience Semin Hematol 41 75 82 10.1053/j.seminhematol.2003.10.008 14727262 (Pubitemid 38057788)
9. BD Humphreys JP Sharman JM Henderson JW Clark PW Marks HG Rennke AX Zhu CC Magee 2004 Gemcitabine-associated thrombotic microangiopathy Cancer 100 2664 2670 10.1002/cncr.20290 15197810 (Pubitemid 38715773)
10. H Izzedine C Isnard-Bagnis V Launay-Vacher L Mercadal I Tostivint O Rixe I Brocheriou E Bourry S Karie S Saeb N Casimir B Billemont G Deray 2006 Gemcitabine-induced thrombotic microangiopathy: a systematic review Nephrol Dial Transplant 21 3038 3045 10.1093/ndt/gfl507 1:CAS:528:DC%2BD28XhtVygurfF 16968717 (Pubitemid 44567072)
11. S Kasper MF Neurath C Huber M Theobald I Scharrer 2007 Protein A immunoadsorption therapy for refractory, mitomycin C-associated thrombotic microangiopathy Transfusion 47 1263 1267 10.1111/j.1537-2995.2007.01266.x 1:CAS:528:DC%2BD2sXosVejurY%3D 17581162 (Pubitemid 46934319)
12. JL Moake 2002 Thrombotic microangiopathies N Engl J Med 347 589 600 10.1056/NEJMra020528 1:CAS:528:DC%2BD38Xmt1yit7Y%3D 12192020 (Pubitemid 34898873)
13. S Muller P Schutt P Bojko MR Nowrousian J Hense S Seeber T Moritz 2005 Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution Ann Hematol 84 110 114 10.1007/s00277-004- 0938-8 1:STN:280:DC%2BD2M%2FgvVGqsw%3D%3D 15340761 (Pubitemid 40089767)
14. AA Onitilo JM Engel LH Clouse KM Gerndt 2009 Successful treatment of mitomycin-induced thrombotic thrombocytopenic purpura with rituximab J Vasc Interv Radiol 20 275 276 10.1016/j.jvir.2008.10.025 19054690
15. S Rodenhuis A Westermann MJ Holtkamp WJ Nooijen JW Baars E van der Wall IC Slaper-Cortenbach JH Schornagel 1996 Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer J Clin Oncol 14 1473 1483 1:CAS:528:DyaK28XjtFKisL8%3D 8622061
16. RW Walker MK Rosenblum SJ Kempin MC Christian 1989 Carboplatin-associated thrombotic microangiopathic hemolytic anemia Cancer 64 1017 1020 10.1002/1097-0142(19890901)64:5<1017::AID-CNCR2820640508>3.0.CO;2-N 1:STN:280:DyaL1Mzjs1KhsQ%3D%3D 2667747
17. RB Walter M Joerger BC Pestalozzi 2002 Gemcitabine-associated hemolytic-uremic syndrome Am J Kidney Dis 40 E16 10.1053/ajkd.2002.35758 12324937
18. M Zupancic PC Shah F Shah-Khan 2007 Gemcitabine-associated thrombotic thrombocytopenic purpura Lancet Oncol 8 634 641 10.1016/S1470-2045(07)70203-6 1:CAS:528:DC%2BD2sXnsFKkurs%3D 17613425 (Pubitemid 46995635)